Here’s a clear, up to date look at the new presbyopia eye drops and what they are, who they help most, what risks they carry, and what you can realistically expect if you try them. Presbyopia is the ...

Age-related near vision loss has long been treated as an inevitable annoyance of getting older, a slow erosion of clarity that sends people reaching for stronger reading glasses every few years. With ...

If you’ve noticed it’s more difficult to focus on objects up close as you age, you’re not alone. Approximately 128 million Americans suffer from a common form of vision loss—and the number is only ...

The gradual loss of near vision that is a natural part of aging can be addressed by glasses, contact lenses, or even surgical procedures. A presbyopia eye drop developed by Tenpoint Therapeutics now ...

What Is Yuvezzi, and Why Does It Matter? Yuvezzi is a new prescription eye drop approved to treat presbyopia, a common condition that makes it harder to see things up close as you age. It's the only ...

The most common side effects were headache, impaired vision, and temporary eye pain or eye irritation. "The FDA approval of Yuvezzi represents a significant milestone for the millions of people in the ...

The FDA has approved YUVEZZI, the first dual-agent eye drop, to treat presbyopia, a leading cause of vision loss in adults. The medication uses a fixed-dose combination of carbachol (2.75%) and ...

Combining two eye drops that have been on the market for at least 30 years each has earned Tenpoint Therapeutics an FDA approval (PDF) for Yuvezzi, a treatment for presbyopia, a common, age-related ...